AlphaMadera's AlphaVal page classifies Marsh & McLennan Companies, Inc. as a Banks, Insurers & Asset Managers business and values it using P/Tangible Book × ROE Quality, then compares the result to the current market price to flag MRSH as undervalued, fairly valued, or overvalued.

What is Marsh & McLennan Companies, Inc.'s fair value?

Fair value for MRSH comes from a P/Tangible Book × ROE Quality model -- the approach AlphaVal selected for this company's Banks, Insurers & Asset Managers classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value MRSH?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. MRSH was classified as Banks, Insurers & Asset Managers and is valued using P/Tangible Book × ROE Quality, built from MRSH's most recent reported fundamentals.

MRSH - Marsh & McLennan Companies, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $203.43 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Mild

Trading 12.1% above fair value

Current Price $185.74

Bear Case $126.57 31.9% downside ($126.57 - $185.74) / $185.74 = -31.9% ROTCE 20.0% → 4.00x TBV

Fair Value $165.66 10.8% downside ($165.66 - $185.74) / $185.74 = -10.8% ROTCE 25.0% → 4.00x TBV

Bull Case $215.36 15.9% upside ($215.36 - $185.74) / $185.74 = 15.9% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

Return on Tangible Equity

27.5%

Cost of Equity

7.5%

Key Value Driver

ROTCE (27.5%) vs. cost of equity (7.5%)

Terminal Value % of EV

Implied Market Multiple 5.87x

Market is pricing in (growth)

Plain-Language Summary

With ROTCE of 27.5% vs. 7.5% cost of equity, fair P/TBV is 4.00x on $31.64 tangible book, implying $165.66 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (34 analysts) $203.43

Analyst Range $182.00 – $234.00

Divergence from AlphaVal 19%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.

⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.

Key Risks

Book value quality matters as much as level — check loan loss reserves
Interest rate sensitivity creates non-linear earnings surprises
Insurance reserving is actuarial, not financial — errors emerge slowly